NCT05108259 - To Compare the Pharmacokinetics and Safety of PBP1502 and Humira in Healthy Subjects | Biotech Hunter

Enrollment

324

Participants

Timeline

Start Date

March 30, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

May 31, 2026

Conditions

Healthy Volunteers

Interventions

DRUG

PBP1502

40 mg/0.4 mL single SC injection via PFS

DRUG

EU-licensed Humira

40 mg/0.4 mL single SC injection via PFS

DRUG

US-licensed Humira

40 mg/0.4 mL single SC injection via PFS

Trial Locations (1)

RECRUITING

Unidad de Fase I. U. Autonoma de Madrid (Clinical Trials Unit, UAM) C/ Arzobispo Morcillo 4, Madrid